Stockscreener 앱 받기
1.06
1.85%
-0.02
전일 마감가:
$1.08
열려 있는:
$1.09
하루 거래량:
28,803
Relative Volume:
0.01
시가총액:
$2.74M
수익:
-
순이익/손실:
$-25.09M
주가수익비율:
-0.2045
EPS:
-5.1824
순현금흐름:
$-18.40M
1주 성능:
-6.19%
1개월 성능:
-20.90%
6개월 성능:
+349.15%
1년 성능:
-32.05%
1일 변동 폭
$1.05
$1.09
1주일 범위
$1.03
$1.13
52주 변동 폭
$0.095
$1.93
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
명칭
Calidi Biotherapeutics Inc
전화
(858) 794-9600
주소
4475 Executive Drive, Suite 200, San Diego
Compare CLDI vs VRTX, REGN, MRNA, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLDI
Calidi Biotherapeutics Inc
|
1.06 | 2.92M | 0 | -25.09M | -18.40M | -5.1824 |
VRTX
Vertex Pharmaceuticals Inc
|
503.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
732.80 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
189.04 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
921.53 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
207.93 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-11-22 | 개시 | H.C. Wainwright | Buy |
| 2023-10-09 | 개시 | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc 주식(CLDI)의 최신 뉴스
Calidi Biotherapeutics (NYSEAMERICAN:CLDI) Races to Fix an Equity Shortfall Before Delisting - kalkine.ca
Calidi Biotherapeutics Addresses NYSE American Compliance Notice - TipRanks
Calidi Biotherapeutics Received Notice of Noncompliance - TradingView
Calidi Biotherapeutics gets NYSE compliance warning but stock surprises - TradingView
Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency - GlobeNewswire
Calidi Biotherapeutics Finalizes $1.2M Registered Direct Stock Offering - kalkinemedia.com
Calidi Biotherapeutics Announces Registered Direct Stock Offering - TipRanks
Calidi Biotherapeutics Raises $1.2 Million in Registered Direct Offering at $1.17 Per Share - TradingView
Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering - Quiver Quantitative
Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire
Calidi Biotherapeutics Inc. (NYSE: CLDI) Share Price, CLDI Stock News, CLDI Share Price & Updates - Kalkine
CLDI Q4 2025 Earnings: Loss Narrows Sharply, Beating Estimates by 73.59%; Shares Rise 3.41%Dividend Earnings Report - vinanet.vn
ARMISTICE CAPITAL, LLC Slashes Calidi Biotherapeutics (CLDI) Sta - GuruFocus
Calidi (CLDI) Quarterly Scorecard: EPS Exceeds Its Estimate in Latest Trading; Market Response: Shares Move Lower 2.90%Dividend Cut Risk - vinanet.vn
Calidi Biotherapeutics (CLDI) grants director 5,000 options - Stock Titan
Calidi director granted 4,000 options at $1.36 | CLDI Insider Trading - Stock Titan
Calidi Biotherapeutics (CLDI) gives CFO 14,000 options with 10-year term - Stock Titan
Calidi Biotherapeutics (CLDI) awards director 4,000 options vesting in 1 year - Stock Titan
Calidi Biotherapeutics (CLDI) CEO awarded 32K options vesting over 4 years - Stock Titan
Calidi Biotherapeutics (CLDI) grants director 6,000 options vesting in 12 months - Stock Titan
Calidi (CLDI) Report Card: The EPS Result Is Above Expectation in the Current Update; Reaction Snapshot: Shares Close 6.62% Lower in the Latest SessionTrough Earnings Signal - vinanet.vn
Calidi (CLDI) Closing Snapshot: Retreats 5.59% to $1.28 in the Current Update; Technical Position: the Near-Term Reference Band Stretches From $1.22 to $1.34 on the DayCalendar Spread Trade - vinanet.vn
Calidi Biotherapeutics Granted Patent for Cell-Based Oncolytic Virus Immunotherapy for Cancer Treatment - ACCESS Newswire
Armistice Capital reports 4.99% Calidi Biotherapeutics (CLDI) stake in Schedule 13G/A - Stock Titan
Calidi Biotherapeutics Inc (CLDI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Form 8K Calidi Biotherapeutics Inc For: 13 August By Investing.com - Investing.com Nigeria
Calidi Biotherapeutics Reports Quarterly Results and Pipeline Progress - TipRanks
Calidi Biotherapeutics Q2 net loss narrows to $4.2M; G&A cuts 48% - scanx.trade
Calidi Biotherapeutics 2Q 2026: Net loss $4.16M, EPS $(2.94) — 10-Q Summary - TradingView
Calidi Biotherapeutics Reports Positive FDA Pre-IND Feedback for CLD-401, Showcases RedTail Platform Data and Cuts G&A Expenses - Quiver Quantitative
Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights - Yahoo Finance
Price to book forward of Calidi Biotherapeutics Inc. – OTC:CLDWW - TradingView
Price to sales forward of Calidi Biotherapeutics Inc. – OTC:CLDWW - TradingView
Calidi Biotherapeutics Inc (CLDI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Calidi Biotherapeutics (CLDI) Holds Steady at $1.63 as Stock Sits Between Support and ResistanceSwing Trade Setups - careplusvn.com
CLDI Q4 2025 Earnings: Narrower Loss of -$0.43 Per Share Beats Estimates, Stock Falls 9.5%Interim Report - dars.gov.et
Calidi Biotherapeutics (CLDI) Insider Trading Activity 2026 $CLDI - MarketBeat
Calidi Biotherapeutics (CLDI) Falls 6.88% to $1.76, Pressing Key Support at $1.67MACD Signal Stocks - dars.gov.et
Calidi Biotherapeutics (CLDI) Jumps 12.5% to $1.89 as Bullish Momentum Builds Toward $1.98 ResistanceMarket Profile - dars.gov.et
Price to sales forward of Calidi Biotherapeutics, Inc. – BOATS:CLDI - TradingView
Calidi Biotherapeutics (CLDI) Surges 9.86% to $1.64 as Buying Pressure BuildsValue Stock Ideas - careplusvn.com
Calidi Biotherapeutics Announces Reverse Stock Split to Maintain NYSE American Listing – July 2026 8-K Filing - Minichart
Calidi Biotherapeutics Implements Reverse Stock Split on NYSE - TipRanks
Price to book forward of Calidi Biotherapeutics, Inc. – AMEX:CLDI - TradingView
Calidi Biotherapeutics To Carry Out 1-for-16 Reverse Stock Split On July 31st, 2026 - Moomoo
Calidi Biotherapeutics Inc (CLDI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CLDI|Calidi Biotherapeutics Inc|Price:0.109|Chg%:+0.009 - TradingKey
Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference - GlobeNewswire
Calidi Biotherapeutics Inc (CLDI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Calidi Biotherapeutics Inc (CLDI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Calidi Biotherapeutics Inc (CLDI) Cash Flow - TradingKey
Calidi Biotherapeutics Inc (CLDI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.28%
0.05%
자본화:
|
볼륨(24시간):